Endoscopy Clinical Trials

Clinical trials related to Endoscopy Procedure

Effect of Dexamethasone, Dexmedetomidine and Their Combination on Postoperative Gastrointestinal Function Measured by I-FEED Score After Elective Laparoscopic Cholecystectomy Surgery: a Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn the effect of Dexamethasone and Dexmedetomidine and Their Combination on Post op. GIT Function Measured by I-FFED Score Post Laparoscopic Cholecystectomy What medical problems do participants have when taking Dexamethasone and Dexmedetomidine? Researchers will compare Dexamethasone and Dexmedetomidine and Their Combination to a placebo (a look-alike substance that contains no drug) to see the effect on Post op. GIT Function Measured by I-FFED Score Post Laparoscopic Cholecystectomy Participants will receive Dexamethasone 8 mg IV + Saline IV (total volume 10 ml) over 10 minutes administered after induction of anesthesia. Participants will receive Dexmedetomidine 0.5 mcg /kg IV + Saline IV (total volume 10 ml) over 10 minutes administered after induction of anesthesia. Participants will receive Dexamethasone 8 mg IV + Dexmedetomidine 0.5 mcg/kg IV+ Saline IV (total volume 10 ml) over 10 minutes administered after induction of anesthesia. Participants will receive Saline IV (total volume 10 ml) over 10 minutes administered after induction of anesthesia

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• . Age 18-65 years.

• American Society of Anesthesiologists (ASA) physical status I or II.

• Scheduled for elective laparoscopic cholecystectomy surgery under general anesthesia.

• Ability to provide written informed consent

Locations
Other Locations
Egypt
Benha University Hospital
RECRUITING
Banhā
Time Frame
Start Date: 2025-12-15
Estimated Completion Date: 2026-08-01
Participants
Target number of participants: 160
Treatments
Active_comparator: Group D (Dexamethasone)
Active_comparator: Group X (Dexmedetomidine)
Active_comparator: Group DX (Combination)
Placebo_comparator: Group P (Placebo)
Related Therapeutic Areas
Sponsors
Leads: Benha University

This content was sourced from clinicaltrials.gov